Aripiprazole treatment of risperidone-induced hyperprolactinemia.
Chen
Jing Xu
JX
Su
Yun Ai
YA
Wang
Shao Li
SL
Bian
Qing Tao
QT
Liu
Yan Hong
YH
Wang
Ning
N
Yang
Fu De
FD
Haile
Colin
C
Kosten
Thomas R
TR
Zhang
Xiang Yang
XY
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000068180:Aripiprazole; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies; D015363:Quinolones / Q000627:therapeutic use*; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D018967:Risperidone